Skip to Content

APO M250 (Mycophenolate Mofetil 250 mg)

Pill with imprint APO M250 is Blue & Pink, Capsule-shape and has been identified as Mycophenolate mofetil 250 mg. It is supplied by Apotex Corp..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; autoimmune hepatitis; organ transplant, rejection prophylaxis; bullous pemphigoid; graft-versus-host disease (and more), and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO M250

Mycophenolate mofetil 250 mg APO M250
Mycophenolate mofetil 250 mg APO M250 Front
Mycophenolate mofetil 250 mg APO M250 Back
Mycophenolate mofetil 250 mg APO M250

Mycophenolate mofetil

APO M250
250 mg
Blue & Pink
Prescription only
Drug Class:
Selective immunosuppressants
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
sodium lauryl sulfate
ferric oxide red
titanium dioxide
indigotindisulfonate sodium
isopropyl alcohol
butyl alcohol
propylene glycol
ferrosoferric oxide
potassium hydroxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
68084-0587 Amerisource Health Services

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.